Literature DB >> 23877207

Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement.

Fabrizio D'Ascenzo1, Flavia Ballocca, Claudio Moretti, Marco Barbanti, Valeria Gasparetto, Marco Mennuni, Maurizio D'Amico, Federico Conrotto, Stefano Salizzoni, Pierluigi Omedè, Chiara Colaci, Giuseppe B Zoccai, Mario Lupo, Giuseppe Tarantini, Massimo Napodanno, Patrizia Presbitero, Imad Sheiban, Corrado Tamburino, Sebastiano Marra, Fiorenzo Gaita.   

Abstract

INTRODUCTION: Despite encouraging short-term and mid-term results, transcatheter aortic valve implantation (TAVI) interventions are still burdened from high rates of adverse events, stressing the need for accurate predictive risk instruments. We compared available surgical risk scores to describe unfavorable outcomes after TAVI.
METHODS: The Age, Creatinine, and Ejection fraction (ACEF) score, the logistic Euroscore, and the Society of Thoracic Surgeons Mortality score (STS) were appraised for their independent power of prediction and for their accuracy (C-index) to predict 30-day and medium-term mortality, according to the Valve Academic Research Consortium.
RESULTS: Nine hundred and sixty-two patients were included. All the scores demonstrated a moderate positive correlation. The closest correlation was observed between the STS score and Euroscore. After logistic regression analysis, STS score and Logistic Euroscore provided independent prediction for short-term all-cause mortality [P = 0.02, odds ratio (OR) 1.1; 95% confidence interval (CI) 1.06-1.31 and P = 0.027, OR 1.03; 95% CI 1.01-1.405]. For in-hospital complications, only STS score performed significantly (P = 0.005, OR 1.05; 95% CI 1.01-1.06). ACEF, Euroscore, and STS score showed low accuracy for 30-day all-cause mortality (area under the curve 0.6, 0.44-0.75; vs. 0.53, 0.42-0.61; vs. 0.62, 0.52-0.71, respectively), whereas STS score performed better for in-hospital complications (0.59, 0.55-0.64). Moreover, after Cox-multivariate adjustments, only ACEF score was near to significance to predict all-cause mortality at mid-term (OR 1.7; 0.8-2.9; P = 0.058), showing the highest accuracy (0.63, 0.55-0.71).
CONCLUSION: In TAVI patients, ACEF score, STS score and Logistic Euroscore provided only a moderate correlation and a low accuracy both for 30-day and medium-term outcomes. Dedicated scores are needed to properly tailor time and kind of approach.

Entities:  

Mesh:

Year:  2013        PMID: 23877207     DOI: 10.2459/JCM.0b013e3283638e26

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  9 in total

1.  Mid-term study of transcatheter aortic valve implantation in an Asian population with severe aortic stenosis: two-year Valve Academic Research Consortium-2 outcomes.

Authors:  Nicholas Chew; Jimmy Kim Fatt Hon; Wei Luen James Yip; Siew Pang Chan; Kian-Keong Poh; William Kok-Fai Kong; Kristine Leok Kheng Teoh; Tiong Cheng Yeo; Huay Cheem Tan; Edgar Lik Wui Tay
Journal:  Singapore Med J       Date:  2016-08-12       Impact factor: 1.858

2.  Deceleration capacity of heart rate predicts 1-year mortality of patients undergoing transcatheter aortic valve implantation.

Authors:  Martin Duckheim; Charlotte Bensch; Linn Kittlitz; Nin Götz; Katharina Klee; Patrick Groga-Bada; Lars Mizera; Meinrad Gawaz; Christine Zuern; Christian Eick
Journal:  Clin Cardiol       Date:  2017-08-28       Impact factor: 2.882

3.  Validation of transcatheter aortic valve implantation risk scores in relation to early and mid-term survival: a single-centre study.

Authors:  Valérie M Collas; Caroline M Van De Heyning; Bernard P Paelinck; Inez E Rodrigus; Christiaan J Vrints; Johan M Bosmans
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-12-20

4.  Risk scores for prediction of 30-day mortality after transcatheter aortic valve implantation: Results from a two-center study in Norway.

Authors:  Didrik Kjønås; Gry Dahle; Henrik Schirmer; Siri Malm; Jo Eidet; Lars Aaberge; Terje Steigen; Svend Aakhus; Rolf Busund; Assami Rösner
Journal:  Health Sci Rep       Date:  2021-05-06

5.  Does the CHA2DS2-Vasc score predict procedural and short-term outcomes in patients undergoing transcatheter aortic valve implantation?

Authors:  Tahir Hamid; Tawfiq R Choudhury; Simon G Anderson; Izhar Hashmi; Saqib Chowdhary; David Hesketh Roberts; Douglas G Fraser; Ragheb Hasan; Vaikom S Mahadevan; Richard Levy
Journal:  Open Heart       Date:  2015-10-22

6.  Network meta-analysis on the comparative effectiveness and safety of transcatheter aortic valve implantation with CoreValve or Sapien devices versus surgical replacement.

Authors:  G Biondi-Zoccai; M Peruzzi; A Abbate; Z M Gertz; U Benedetto; E Tonelli; F D'Ascenzo; A Giordano; P Agostoni; G Frati
Journal:  Heart Lung Vessel       Date:  2014

7.  Prognostic Impact of Pre-Transcatheter and Post-Transcatheter Aortic Valve Intervention Troponin: A Large Cohort Study.

Authors:  Mariama Akodad; Marco Spaziano; Bernard Chevalier; Philippe Garot; Hakim Benamer; Annabelle Dinan-Zannier; Xavier Troussier; Thierry Unterseeh; Stéphane Champagne; Thomas Hovasse; Thierry Lefèvre
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

8.  Rockwood Clinical Frailty Scale as a predictor of adverse outcomes among older adults undergoing aortic valve replacement: a protocol for a systematic review.

Authors:  Tadhg Prendiville; Aoife Leahy; Laura Quinlan; Anastasia Saleh; Elaine Shanahan; Ahmed Gabr; Catherine Peters; Ivan Casserly; Margaret O'Connor; Rose Galvin
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

9.  Clinical and Echocardiographic Parameters Predicting 1- and 2-Year Mortality After Transcatheter Aortic Valve Implantation.

Authors:  Didrik Kjønås; Henrik Schirmer; Svend Aakhus; Jo Eidet; Siri Malm; Lars Aaberge; Rolf Busund; Assami Rösner
Journal:  Front Cardiovasc Med       Date:  2021-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.